Results
Upcoming earnings reports
Scheduled quarterly report dates, soonest first, with the consensus EPS and revenue estimates the earnings calendar carries. Dates are set by the companies and can move.
SectorAll 144Industrials 33Technology 29Consumer Cyclical 25Consumer Defensive 15Healthcare 13Energy 12Utilities 6Basic Materials 4Financial Services 4Communication Services 3
| Company | Sector | Report date | Est. EPS | Est. revenue | Market cap |
|---|---|---|---|---|---|
| Wed, Nov 18, 2026 | |||||
| PREPrenetics Global Limited - Class A Ordinary Share | Healthcare | Wed, Nov 18, 2026 | −$0.82 | $63.2M | $277M |
| ICCMIceCure Medical Ltd. | Healthcare | Wed, Nov 18, 2026 | −$1.16 | $0.9M | $2M |
| BRTXBioRestorative Therapies, Inc. | Healthcare | Wed, Nov 18, 2026 | −$1.40 | $0.7M | $2M |
| EDVAEndovia Health Sciences, Inc. | Healthcare | Wed, Nov 18, 2026 | −$12.80 | $5.0M | $1M |
| Thu, Nov 19, 2026 | |||||
| DRTSAlpha Tau Medical Ltd. | Healthcare | Thu, Nov 19, 2026 | −$0.15 | $0.1M | $1.1B |
| NNOXNANO-X IMAGING LTD | Healthcare | Thu, Nov 19, 2026 | −$0.15 | $5.3M | $23M |
| EVGNEvogene Ltd. | Healthcare | Thu, Nov 19, 2026 | −$0.19 | $0.4M | $3M |
| Mon, Nov 23, 2026 | |||||
| AAgilent Technologies, Inc. | Healthcare | Mon, Nov 23, 2026 | $1.73 | $1.99B | $48.6B |
| Tue, Nov 24, 2026 | |||||
| MDTMedtronic plc | Healthcare | Tue, Nov 24, 2026 | $1.33 | $9.48B | $130.9B |
| EMBCEmbecta Corp. | Healthcare | Tue, Nov 24, 2026 | $0.31 | $267M | $348M |
| AVXLAnavex Life Sciences Corp. | Healthcare | Tue, Nov 24, 2026 | −$0.11 | — | $69M |
| LEXXLexaria Bioscience Corp. | Healthcare | Tue, Nov 24, 2026 | −$0.90 | $0.1M | $7M |
| Wed, Nov 25, 2026 | |||||
| ALPAlpha Compute Corp | Healthcare | Wed, Nov 25, 2026 | −$3.50 | $5.3M | $1M |
- Dates and consensus estimates come from the earnings calendar; a blank estimate means none is published there. Estimates are analysts' figures, not company guidance.
- A date can change after it is announced. Once a company reports, it moves to Latest results.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.